Although initially approved and marketed specifically for erectile dysfunction, Pfizer and later competitors used aggressive targeted marketing to catapult the drug from an erectile dysfunction treatment to a lifestyle pill pocketed by nervous 30-year-olds heading out on Internet dates.
Another drug is experiencing a similar meteoric explosion - only the downfall could be far worse.
[
add
]
[
|
|
...
]